Global Advanced Therapy Medicinal Products Cdmo Market Size & Outlook
Global advanced therapy medicinal products cdmo market, 2018-2030 (US$M)
Related Markets
Global advanced therapy medicinal products cdmo market highlights
- The global advanced therapy medicinal products cdmo market generated a revenue of USD 6,647.7 million in 2024 and is expected to reach USD 18,801.2 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 19.1% by 2030.
- In terms of segment, gene therapy accounted for a revenue of USD 3,813.6 million in 2024.
- Cell Therapy is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 6,647.7 million |
| Market revenue in 2030 | USD 18,801.2 million |
| Growth rate | 19.1% (CAGR from 2025 to 2030) |
| Largest segment | Gene therapy |
| Fastest growing segment | Cell Therapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gene Therapy, Cell Therapy, Tissue Engineered, Others (Combined ATMPs, for example biodegradable matric or scaffold) |
Other key industry trends
- In terms of revenue, the North America accounted for 48.8% of the global advanced therapy medicinal products cdmo market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 1,788.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Advanced Therapy Medicinal Products CDMO Market Scope
Advanced Therapy Medicinal Products CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Rentschler Biopharma SE | View profile | 501-1000 | Laupheim, Baden-Wurttemberg, Germany, Europe | https://www.rentschler-biopharma.com |
| CGT Catapult | View profile | 251-500 | London, England, United Kingdom, Europe | https://ct.catapult.org.uk |
| Bio Elpida | View profile | 11-50 | Lyon, Rhone-Alpes, France, Europe | http://www.bio-elpida.com |
| CELONIC | View profile | 251-500 | Basel, Basel-Stadt, Switzerland, Europe | http://www.celonic.com |
| Resonac Holdings Corp | View profile | 23840 | 1-9-1, Higashi-Shimbashi, Tokyo Shiodome Building, Minato-ku, Tokyo, Japan, 105-7325 | https://www.resonac.com |
| Cencora Inc | View profile | 46000 | 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 | https://www.cencora.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| AGC Inc | View profile | 61671 | 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, Japan, 100-8405 | https://www.agc.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Global advanced therapy medicinal products cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to advanced therapy medicinal products cdmo market will help companies and investors design strategic landscapes.
Gene therapy was the largest segment with a revenue share of 57.37% in 2024. Horizon Databook has segmented the Global advanced therapy medicinal products cdmo market based on gene therapy, cell therapy, tissue engineered, others (combined atmps, for example biodegradable matric or scaffold) covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Advanced Therapy Medicinal Products CDMO Product Outlook (Revenue, USD Million, 2018-2030)
- Others (Combined ATMPs, for example biodegradable matric or scaffold)
- Gene Therapy
- Cell Therapy
- Tissue Engineered
- Global Advanced Therapy Medicinal Products CDMO Phase Outlook (Revenue, USD Million, 2018-2030)
- Phase IV
- Phase II
- Phase I
- Phase III
- Global Advanced Therapy Medicinal Products CDMO Indication Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Immunology & inflammation
- Musculoskeletal
- Opthalmology
- Haematology
- Gastenterology
- Others Indication
- Cardiology
- Infectious disease
- Endocrine, metabolic, genetic
- Central nervous system
- Dermatology
Reasons to subscribe to Global advanced therapy medicinal products cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global advanced therapy medicinal products cdmo market databook
-
Our clientele includes a mix of advanced therapy medicinal products cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global advanced therapy medicinal products cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global advanced therapy medicinal products cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global advanced therapy medicinal products cdmo market size, by regions, 2018-2030 (US$M)
Top 10 countries: Advanced therapy medicinal products cdmo market size, 2024 (US$M)
Global advanced therapy medicinal products cdmo market share, by phase, 2024 & 2030 (%, US$M)
Advanced therapy medicinal products cdmo market: Opportunity assessment by country
Global advanced therapy medicinal products cdmo market, by region, 2024 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
